CURRENT NEWS

NEWS ARCHIVE

EVENTS

WHITE PAPERS

VIDEOS

Have a question or topic idea for The Life Science Report? Submit it here.

Industry Podcast
The Life Science Report

The Back Bay Life Science Report brings you expert insights from our advisors and investment bankers on life science development. Every month, we speak with life sciences executives and developers, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions.

Start listening for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.

Tune in bi-monthly for our latest podcast release.

Latest Podcast Episodes

Featured
The Current Dynamics in Capital Markets
The Current Dynamics in Capital Markets
Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
The Most Notable Product Approvals of 2023
The Most Notable Product Approvals of 2023
Monthly Roundup of News from Healthcare Development
Monthly Roundup of News from Healthcare Development
The Current and Future Landscape of Healthcare IPO Markets
The Current and Future Landscape of Healthcare IPO Markets
The Heart of the Matter: Behind the Shifting Interest in Cardiovascular Disease - A conversation on the rising trends in the cardiology space
The Heart of the Matter: Behind the Shifting Interest in Cardiovascular Disease - A conversation on the rising trends in the cardiology space
The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates
The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates
Investing and Development in Health Tech & Digital Medicine
Investing and Development in Health Tech & Digital Medicine
Contingencies for Biopharma, Medtech Deal Planning in a Down Market
Contingencies for Biopharma, Medtech Deal Planning in a Down Market
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022
Preparing BioPharma and Medtech Companies for Public Listing Back Bay Life Science Advisors and Nasdaq Nordic
Preparing BioPharma and Medtech Companies for Public Listing Back Bay Life Science Advisors and Nasdaq Nordic
The Promising Field of Targeted Protein Degraders (TPDs)
The Promising Field of Targeted Protein Degraders (TPDs)
Developer Questions on Pricing and Market Access
Developer Questions on Pricing and Market Access
Living Medicines – Current and Future Uses of Car T Cells
Living Medicines – Current and Future Uses of Car T Cells
The Evolving Regulatory Framework for Novel Medicines in the EU
The Evolving Regulatory Framework for Novel Medicines in the EU
The Commercial Potential of Optogenetic Therapies
The Commercial Potential of Optogenetic Therapies
The Latest on Antibiotic Development—with Antabio
The Latest on Antibiotic Development—with Antabio
Best Practices for Successful Sell-Side Licensing, Partnering and M&A
Best Practices for Successful Sell-Side Licensing, Partnering and M&A
Cell and Gene Therapy Investment Trends
Cell and Gene Therapy Investment Trends